Envisia Therapeutics
Get Full AccessDescription
- Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
-
Headquarters:419 Davis Drive Suite 100, Morrisville, North Carolina, United States
More -
Phone Number: +1 919-973-1440
-
Website: https://www.envisiatherapeutics.com
-
Employees:8
-
Revenue:$1 - 10M
-
Legal Name:Envisia Therapeutics
-
Envisia Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Envisia Therapeutics
-
Where are Envisia Therapeutics's Headquarters?
Envisia Therapeutics's Headquarters are in 419 Davis Drive Suite 100,Morrisville,North Carolina,United States
-
What is Envisia Therapeutics's phone number?
Envisia Therapeutics's phone number is +1 919-973-1440
-
What is Envisia Therapeutics's official website?
Envisia Therapeutics's official website is https://www.envisiatherapeutics.com
-
What is Envisia Therapeutics's Revenue?
Envisia Therapeutics's revenue is $1 - 10M
-
What is Envisia Therapeutics's NAICS code?
Envisia Therapeutics's NAICS code is 541713
-
How many employees are working in Envisia Therapeutics
Envisia Therapeutics has 8 employees
-
What is Envisia Therapeutics's Industry?
Envisia Therapeutics is in the industry of Biotechnology

